India proposes to make compensation for trial-related injuries and registration of ethics panels mandatory
This article was originally published in Scrip
The Indian government wants feedback on proposals to introduce mandatory requirements for compensating clinical trial subjects for trial-related injuries/deaths and for registering ethics committees with the licensing authority before they can review or approve a trial protocol.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.